Skip to main content
. 2023 Apr 26;12(5):282–289. doi: 10.1093/jpids/piad027

Table 1.

Comparison of Baseline Characteristics in Children With Respiratory Tract Infection and Detection of HBoV1 DNA, HBoV1-mRNA and RSV

HBoV1-DNA (n = 274) HBoV1-mRNA+ vs. mRNA- RSV (n = 1447)a HBoV1-mRNA+ vs. RSV
mRNA+ (n = 130)a mRNA- (n = 144) OR (95% CI) OR (95% CI)
Age, median (interquartile range), months 15.3 (12.1–19.6) 18.3 (13.2–26.9)b 7.9 (2.6–18.9)b
Age group (months)
 <6 7 (5.4) 4 (2.8) Ref. 614 (42.4) Ref.
 6–11 24 (18.5) 23 (16.0) 0.60 (0.1–2.3) 251 (17.3) 8.4 (3.6–19.7)
 12–17 56 (43.1) 42 (29.2) 0.76 (0.21–2.8) 196 (13.5) 25.1 (11.2–55.9)
 18–23 23 (17.7) 31 (21.5) 0.42 (0.11–1.6) 161 (11.1) 12.5 (5.3–29.7)
 24–59 20 (15.4) 43 (29.9) 0.27 (0.07–1.0) 206 (14.2) 8.5 (0.94–2.0)
 ≥60 0 (0.0) 1 (0.7) 19 (1.3)
Male sex 85 (65.4) 87 (60.4) 1.2 (0.76–2.0) 838 (57.9) 1.37 (0.94–2.0)
Premature birth (gestational age <36 weeks) 16/120 (13.3) 26/132 (19.7) 0.63 (0.32–1.2) 188/1427 (13.2) 1.0 (0.59–1.8)
≥1 chronic diseasec 33 (25.4) 43 (29.9) 0.8 (0.47-1.4) 247 (17.1) 1.7 (1.1-2.5)

The data represents the no. (%) of children unless otherwise specified. Strength of associations estimated by Pearson χ2 test and binary logistic regression as appropriate, and given as OR and 95% CI. CI, confidence interval; HBoV1, human bocavirus 1; OR, odds ratio; RSV, respiratory syncytial virus.

aTwenty children with both HBoV1-mRNA and RSV were included in the HBoV1-mRNA group only.

b p < .001 by Mann–Whitney U test.

cHeart disease, neurologic disease, and/or pulmonary disease.